1 |
de Vries F, Huckriede J, Wichapong K, Reutelingsperger C, Nicolaes GAF. The role of extracellular histones in COVID-19. J Intern Med 2023;293:275-92. [PMID: 36382685 DOI: 10.1111/joim.13585] [Reference Citation Analysis]
|
2 |
Lei H. A two-gene marker for the two-tiered innate immune response in COVID-19 patients. PLoS One 2023;18:e0280392. [PMID: 36649304 DOI: 10.1371/journal.pone.0280392] [Reference Citation Analysis]
|
3 |
De R, Azad RK. Molecular signatures in the progression of COVID-19 severity. Sci Rep 2022;12:22058. [PMID: 36543855 DOI: 10.1038/s41598-022-26657-2] [Reference Citation Analysis]
|
4 |
Edinger F, Edinger S, Koch C, Markmann M, Hecker M, Sander M, Schneck E. Peak Plasma Levels of mtDNA Serve as a Predictive Biomarker for COVID-19 in-Hospital Mortality. J Clin Med 2022;11. [PMID: 36498735 DOI: 10.3390/jcm11237161] [Reference Citation Analysis]
|
5 |
Rinchai D, Chaussabel D. Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker. F1000Res 2022;11:1294. [DOI: 10.12688/f1000research.126721.1] [Reference Citation Analysis]
|
6 |
Schneider F, Le Borgne P, Herbrecht JE, Danion F, Solis M, Hellé S, Betscha C, Clere-Jehl R, Lefebvre F, Castelain V, Goumon Y, Metz-Boutigue MH. Assessment of plasma Catestatin in COVID-19 reveals a hitherto unknown inflammatory activity with impact on morbidity-mortality. Front Immunol 2022;13:985472. [PMID: 36248786 DOI: 10.3389/fimmu.2022.985472] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
7 |
Feng Z, Ren X, Duren Z, Wang Y. Human Genetic Variants Associated with COVID-19 Severity are Enriched in Immune and Epithelium Regulatory Networks. Phenomics 2022. [DOI: 10.1007/s43657-022-00066-x] [Reference Citation Analysis]
|
8 |
Assylbekova A, Zhanapiya A, Grzywa R, Sienczyk M, Schönbach C, Burster T. Camostat Does Not Inhibit the Proteolytic Activity of Neutrophil Serine Proteases. Pharmaceuticals 2022;15:500. [DOI: 10.3390/ph15050500] [Reference Citation Analysis]
|